General Announcement::Intimation of Appointment of Ms. Saira Ramasastry as an Additional Director - Independent Director

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
28-Mar-2019 21:44:14
Status
New
Announcement Sub Title
Intimation of Appointment of Ms. Saira Ramasastry as an Additional Director - Independent Director
Announcement Reference
SG190328OTHR38IQ
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
28/03/2019 00:00:00
Description (Please provide a detailed description of the event in the box below)
Sub: Intimation of Appointment of Ms. Sona Saira Ramasastry {DIN-0008398547) as an Additional Director - Independent Director

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ("Listing Regulations"), we are pleased to inform that on recommendation of Nomination & Remuneration Committee, the Board has appointed Ms. Saira as an Additional Director to hold office as an Independent Director of the Company for a term of Five years with effect from 1st April, 2019, not liable to retire by rotation, subject to the approval of the shareholders at the ensuing General Meeting.

Ms. Saira is not debarred from holding the office of director by virtue of any order passed by SEBI or any other authority.

Attachments

SGX_Appointment_of_Independent_Director.pdf
Total size =1087K